You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
CoreValve™ and Evolut™ TAVI systems are the only platforms to demonstrate a durability benefit over SAVR at 5 years1,2.
Significantly lower rate of SVD with TAVI vs Surgery through 5 years in small annuli2. This difference in SVD was more profound in patients with smaller ( ≤23 mm) annuli (5.86% surgery vs 1.39% TAVI; P=0.049)2, but a trend was also found in patients with larger ( >23 mm) annuli (3.96% surgery vs 2.48% TAVI; P=0.067)2.
Corevalve Evolut Pooled Analysis
5-Year SVD In Smaller (≤23 mm) Annular Diameters2
In pooled analysis of intermediate and high-risk patients. Devices used: Corevalve 88.5%, Evolut R 11.5%.
Reardon M. 5-Year Incidence, Timing and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprosthesis: Insights from the CoreValve US Pivotal and SURTAVI Trials. Presented at ACC 2022.
Structural Valve Deterioration (SVD) was defined as an increase in mean gradient ≥10 mm Hg from discharge/30-day echo to last available echo AND mean gradient ≥20 mm Hg at last available echo OR new onset/increase of intra-prosthetic aortic regurgitation (AR) ≥ moderate.
See the CoreValve™ Evolut™ R, the CoreValve™ Evolut™ PRO and the Evolut™ PRO+ device manuals for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.
For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu. For applicable products, consult instructions for use on manuals.medtronic.com. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat© Reader with the browser.
The commercial name of the Evolut™ R device is Medtronic CoreValve™ Evolut™ R System, the commercial name of the Evolut™ PRO device is Medtronic CoreValve™ Evolut™ PRO System, and the commercial name of the Evolut™ PRO+ device is Medtronic Evolut™ PRO+ System.
Medtronic and the Medtronic logo are trademarks of Medtronic. ™*Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.